Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Oncoimmunology|June 5, 2013
Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodiesEvan J LipsonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2011
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanomaEvan J Lipson, Charles G DrakeOncology (Williston Park, N.Y.)|November 12, 2014
Identification and management of toxicities from immune checkpoint-blocking drugsBenjamin A Teply, Evan J LipsonFuture Oncology (London, England)|March 24, 2015
Nivolumab: targeting PD-1 to bolster antitumor immunityJulie R Brahmer, Hans Hammers, Evan J LipsonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2019
Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse EventErica C Nakajima, Evan J Lipson, Julie R BrahmerNature Reviews. Clinical Oncology|November 20, 2013
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancerCharles G Drake, Evan J Lipson, Julie R BrahmerJournal of the American Academy of Dermatology|May 25, 2020
Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: A US national and tertiary care center studySaleh Rachidi, Zhengyi Deng, Danielle Y Sullivan, et al.Journal for Immunotherapy of Cancer|March 24, 2018
Immunotherapy for Merkel cell carcinoma: a turning point in patient careIsaac S Chan, Shailender Bhatia, Howard L Kaufman, et al.Radiology Case Reports|January 17, 2022
Acute axillary lymphadenopathy detected shortly after COVID-19 vaccination found to be due to newly diagnosed metastatic melanomaDavid M Gullotti, Evan J Lipson, Elliot K Fishman, et al.Clinical Transplantation|July 13, 2005
Patient and graft outcomes following liver transplantation for sarcoidosisEvan J Lipson, Maria Isabel Fiel, Sander S Florman, et al.Pageof 11